Combination pharmacotherapy: A mixture of small doses of naltrexone, fluoxetine, and a thyrotropin-releasing hormone analogue reduces alcohol intake in three strains of alcohol-preferring rats

Alcohol and Alcoholism

Volumn 35, Issue 1, 2000, Pages 76-83

  Rezvani, Amir H ^a,b   Overstreet, David H ^b   Mason, George A ^b   Janowsky, David S ^b   Hamedi, Mani ^b   Clark Jr , E ^b   Yang, Ying ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; FLUOXETINE; NALTREXONE; OPIATE; PROTIRELIN DERIVATIVE; TALTIRELIN;

ALCOHOL CONSUMPTION; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DRUG EFFICACY; FLUID INTAKE; FOOD INTAKE; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONINERGIC SYSTEM;

EID: 0033950679     PISSN: 07350414     EISSN: None     Source Type: Journal    
DOI: 10.1093/alcalc/35.1.76     Document Type: Article

References (53)

1. Anton, R. F., Moak, D. H. and Latham, P. K. (1996) The Obsessive Compulsive Drinking Scale: a new method of assessing outcome in alcoholism treatment studies. Archives of General Psychiatry 53, 225-231.
2. Bakris, G. L. and Williams, B. (1995) Angiotensin converting enzyme inhibitors and calcium antagonists alone or combined: does the progression of diabetic renal disease differ? Journal of Hypertension 13, S95-S101.
3. Benjamin, D., Grant, E. R. and Pohorecky, L. A. (1993) Naltrexone reverses ethanol-induced dopamine release in the nucleus accumbens in awake, freely moving rats. Brain Research 621, 137-140.
4. Birkenhager, T. K., Moleman, P. and Nolen, W. A. (1995) Benzodiazepines for depression? A review of the literature. International Clinical Psychopharmacology 10, 181-195.
5. Chalmers, J. (1993) The place of combination therapy in the treatment of hypertension. Clinical and Experimental Hypertension 15, 1299-1313.
6. Cowen, M. S., Rezvani, A. H., Jarrott, B. and Lawerence, A. J. (1999) Ethanol consumption by Fawn-Hooded rats following abstinence: effects of naltrexone and changes in μ-opioid receptor density. Alcoholism: Clinical and Experimental Research 23, 1008-1014.
7. Devine, D. P., Leone, P. and Wise, R. A. (1993) Mesolimbic dopamine neurotransmission by administration of μ-opioid receptor antagonists. European Journal of Pharmacology 24, 55-64.
8. DiChiara, G. and Imperato, A. (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proceeding of the National Academy of Sciences of the USA 85, 5274-5278.
9. Farren, C. K., Catapano, D. and O'Malley, S. (1997) Sertraline with naltrexone versus naltrexone alone in the treatment of alcohol dependence. Alcoholism: Clinical and Experimental Research 21 (suppl.), 64 (Abstract no. 366).
10. Froehlich, J. C. and Li, T.-K. (1993) Recent developments in alcoholism: opioid peptides. Recent Developments in Alcoholism 11, 187-205.
11. Froehlich, J. C., Harts, J., Lumeng, L. and Li, T.-K. (1990) Naloxone attenuates voluntary ethanol intake in rats selectively bred for high ethanol preference. Pharmacology, Biochemistry and Behavior 35, 385-390.
12. Gardell, L. R., Whalen, C. A., Chattophadyay, S., Cavallaro, C. A., Hubbell, C. L. and Reid, L. D. (1997) Combination of naltrexone and fluoxetine on rats' propensity to take alcoholic beverage. Alcoholism: Clinical and Experimental Research 21, 1435-1439.
13. 3 receptors in drug dependence. Drug and Alcohol Dependence 38, 155-171.
14. Hodge, C. A., Haraguchi, M., Erickson, H. L. and Samson, H. H. (1993a) Ventral tegmental microinjections of quinpirole decrease ethanol and sucrose-reinforced responding. Alcoholism: Clinical and Experimental Research 17, 370-375.
15. 3 antagonist ICS 205-930. Alcohol 10, 191-196.
16. Koob, G. F., Rassnick, S., Heinrichs, S. and Weiss, F. (1994) Alcohol, the reward system and dependence. EXS 71, 103-114.
17. 2a receptors in alcohol drinking: preference in HAD rats is inhibited by combination treatment with naltrexone and amperozide. Alcohol 13, 53-57.
18. 3 receptor antagonists in the regulation of alcohol intake. Alcohol and Alcoholism 29 (suppl. 2), 545-549.
19. Levine, J. H., Ferdinand, K. C., Cargo, P., Laine, H. and Lefkowitz, M. (1995) Additive effects of verapamil and enalapril in the treatment of mild to moderate hypertension. American Journal of Hypertension 8, 494-499.
20. Li, T-K. and McBride, W. J. (1995) Pharmacogenetic models of alcoholism. Clinical Neuroscience 3, 182-185.
21. Mason, G. A., Rezvani, A. H., Grady, D. R. and Garbutt, J. C. (1994) The subchronic effects of the TRH analog TA-0910 and bromocriptine on alcohol preference in alcohol-preferring rats: development of tolerance and cross-tolerance. Alcoholism: Clinical and Experimental Research 18, 1196-1201.
22. Mason, G. A., Rezvani, A. H., Overstreet, D. H. and Garbutt, J. C. (1996) The thyrotropin releasing hormone analog TA-0910 reduces voluntary alcohol intake of P rats subchronically in a limited scheduled access paradigm. Alcoholism: Clinical and Experimental Research 20, 1000-1003.
23. Mason, G. A., Rezvani, A. H., Overstreet, D. H., Hamedi, M., Walker, C. H., Yang, Y. and Garbutt, J. C. (1997) Involvement of dopamine D2 receptors in the suppressive effect of the thyrotropin releasing hormone analog TA-0910 on alcohol intake in P rats. Alcoholism: Clinical and Experimental Research 21, 1623-1629.
24. McBride, W. J., Murphy, J. M., Lumeng, L. and Li, T.-K. (1990) Serotonin, dopamine and GABA involvement in alcohol drinking of selectively bred rats. Alcohol 7, 199-205.
25. Menard, J. (1993) Critical assessment of combination therapy development. Blood Pressure 1, 5-9.
26. Murphy, J. M., Waller, M. B., Gatto, G. J., McBride, W. J., Lumeng, L. and Li, T.-K. (1988) Effects of fluoxetine on the intragastric self-administration of ethanol in the alcohol preferring P line of rats. Alcohol 5, 282-286.
27. Nakagawa, H., Kobayashi, K., Tono, T., Fukuda, K., Shinn, E., Mishima, H., YagyKobayashi, T. and Kikkawa N. (1996) Combination of intra-hepatic arterial infusion of low dose cisplatin and oral administration of high-dose doxyfluridine for patients with live metastases of gastric cancer. Japanese Journal of Cancer and Chemotherapy 23, 783-785.
28. O'Malley, S. S., Jaffe, A. J., Chang, G., Schottenfeld, R. S., Meyer, R. E. and Rounsaville, B. (1992) Naltrexone and coping skills therapy for alcohol dependence. Archives of General Psychiatry 49, 475-481.
29. Overstreet, D. H., Rezvani, A. H. and Kampov-Polevoy, A. B. (1995) Strain-dependent suppressant effects of dopaminergic, serotonergic and opioidergic agents on alcohol intake. Society for Neuroscience Abstract 666.16.
30. Overstreet, D. H., Lee, Y. W., Rezvani, A. H., Pei, Y. H., Criswell, H. E. and Janowsky, D. S. (1996) Suppression of alcohol intake after administration of the Chinese herbal medicine, NPI-028, and its derivatives. Alcoholism: Clinical and Experimental Research 20, 221-227.
31. Prisant, L. M., Weir, M. R., Papademetriou, V., Weber, M. A., Adegbile, I. A., Alemayehu, D., Lefkowitz, M. P. and Carr, A. A. (1995) Low-dose drug combination therapy: an alternative first-line approach to hypertension treatment. American Heart Journal 130, 359-366.
32. 2+ channel inhibitor, GOE 5438. Psychopharmacology 107, 447-452.
33. Reid, L. D., Delconte, J. D., Nichols, M. L., Bilsky, E. J. and Hubbell, C. L. (1991) Tests of opioid deficiency hypotheses of alcoholism. Alcohol 8, 247-257.
34. Rezvani, A. H. and Janowsky, D. S. (1990) Decrease of alcohol consumption by verapamil in alcohol preferring rats. Progress in Neuro-Psychopharmacology and Biological Psychiatry 14, 623-631.
35. Rezvani, A. H. and Grady, D. R. (1994) Suppression of alcohol consumption by fenfluramine in Fawn-Hooded rats with serotonin dysfunction. Pharmacology, Biochemistry and Behavior 48, 105-110.
36. 2+-channel blockade reverses ethanol induced poikilothermia in the rat. Alcohol 3, 273-279.
37. Rezvani, A. H., Overstreet, D. H. and Janowsky D. S. (1990) Genetic serotonin deficiency and alcohol preference in the Fawn-Hooded rats. Alcohol and Alcoholism 25, 573-575.
38. 2+-channel blockers on alcohol preference in alcohol-drinking monkeys. Alcohol and Alcoholism 26, 161-167.
39. Rezvani, A. H., Overstreet, D. H. and Janowsky, D. S. (1991b) Drug-induced reductions in ethanol intake in alcohol preferring and Fawn-Hooded rats. Alcohol and Alcoholism 26 (suppl. 1), 433-437.
40. Rezvani, A. H., Garbutt, J. C., Shimoda, K., Garges, P. L., Janowsky, D. S. and Mason, G. A. (1992) Attenuation of alcohol preference in alcohol-preferring rats by a novel TRH analogue, TA-0910. Alcoholism: Clinical and Experimental Research 16, 326-330.
41. Rezvani, A. H., Mason, G. A., Garbutt, J. C., Janowsky, D. S. and Overstreet, D. H. (1993) Reductions of tolerance to anti-craving drugs for alcohol. Alcoholism: Clinical and Experimental Research 17, 515.
42. Rezvani, A. H., Overstreet, D. H. and Lee, Y. W. (1995) Attenuation of alcohol intake by Ibogaine in three strains of alcohol preferring rats. Pharmacology, Biochemistry and Behavior 52, 615-620.
43. Rezvani, A. H., Overstreet, D. H. and McArthur, R. (1996) Amperozide, a 5-HT-2a receptor antagonist, is more effective in reducing alcohol intake than fluoxetine or duloxetine. Society for Neuroscience Abstract 456.13.
44. Rose, J. E. and Levin, E. D. (1992) Concurrent agonist-antagonist administration for the analysis and treatment of drug dependence. Pharmacology, Biochemistry and Behavior 41, 219-226.
45. Rosenthal, T. C. (1992) Combining insulin and oral agents in diabetes: indications and controversies. American Family Physician 46, 1721-1727.
46. Salloum, I. M., Cornelius, J. R., Thase, M. E., Daley, D. C., Kirisci, L. and Spotts C. (1998) Naltrexone utility in depressed alcoholics. Psychopharmacology Bulletin 34, 111-115.
47. Schumm-Draeger, P. M. (1993) Drug therapy of goiter. Iodine, thyroid hormones or combined therapy. Zeitschrift fur die Gesamte Innere Medizin und Ihre Grenzgebiete 48, 592-598.
48. Tanada, G., Frau, R. and DiChiara, G. (1995) Local 5-HT3 receptors mediate fluoxetine but not desipramine-induced increase of extracellular dopamine in the prefrontal cortex. Psychopharmacology 119, 15-19.
49. Tiller, J. W., Mitchell, P. and Burrows, G. D. (1992) Monoamine oxidase inhibitors (MAOI) or reversible inhibitors of monoamine oxidase (RIMA)/tricyclic antidepressant (TCA) combination therapy. Australian and New Zealand Journal of Psychiatry 26, 327-329.
50. Volpicelli, J. R., Alterman, A. I., Hayashida, M. and O'Brien, C. P. (1992) Naltrexone in the treatment of alcohol dependence. Archives of General Psychiatry 49, 876-880.
51. Williams, L. D. and Mason, B. J. (1997) Combination pharmacotherapy in nalmefene non-responders. Alcoholism: Clinical and Experimental Research, 21 (suppl.), 33, Abstract 179.
52. Yamamura, M., Kinoshita, K., Nakagawa, H. and Ishida, R. (1991) Pharmacological study of TA-0910, a new thyrotropin-releasing hormone (TRH) analog (II): involvement of the DA system in locomotor stimulating action of TA-0910. Japanese Journal of Pharmacology 55, 57-68.
53. Zink, R. W., Rohrbach, K. and Froehlich, J. C. (1997) Naltrexone and fluoxetine act synergistically to decrease alcohol intake. Alcoholism: Clinical and Experimental Research 21 (suppl.), 105, Abstract no. 606.